Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Drugs

Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
Jun 11, 2026, 16:19 | Drugs
Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
Jack Shuang Hou, Diagnostic Executive, Microfluidics and Immunoassay Specialist, shared on LinkedIn: ''Bayer Advances Asundexian as…
Chris Boshoff: FDA Approves Our Treatment for Hemophilia A and B for 2 New Patient Populations
Jun 9, 2026, 11:36 | Drugs
Chris Boshoff: FDA Approves Our Treatment for Hemophilia A and B for 2 New Patient Populations
Chris Boshoff, Chief Scientific Officer and President of Research and Development at Pfizer, shared on…
Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
Jun 9, 2026, 04:47 | Drugs
Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post…
Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
May 30, 2026, 18:12 | Drugs
Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
Khokon Miah Akanda, Senior Brand Executive at Apex Pharma Limited, shared on LinkedIn: "FDA approves a…
FDA Approves Jakafi XR (Ruxolitinib Extended-Releas) for Myelofibrosis, Polycythemia Vera and GVHD
May 4, 2026, 02:41 | Drugs
FDA Approves Jakafi XR (Ruxolitinib Extended-Releas) for Myelofibrosis, Polycythemia Vera and GVHD
Jakafi XR (ruxolitinib extended-release tablets) received U.S. Food and Drug Administration approval for the treatment…
Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
May 2, 2026, 14:04 | Drugs
Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo…
Anusha Narla: Understanding Drug-Food Interaction - Levithyroxine
Apr 27, 2026, 14:33 | Drugs
Anusha Narla: Understanding Drug-Food Interaction - Levithyroxine
Anusha Narla, Academic Team Lead at Medclinigen, shared a post on LinkedIn: "Understanding drug-food interaction:…
Jack Shuang Hou: CorTec Wins FDA TAP Entry for Brain Interchange
Apr 24, 2026, 08:20 | Drugs
Jack Shuang Hou: CorTec Wins FDA TAP Entry for Brain Interchange
Jack Shuang Hou, Scientific Director at Jtests and CorDx, shared on LinkedIn: ''CorTec Wins FDA…
Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
Apr 6, 2026, 16:39 | Drugs
Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
Dhinesh Selvaraju, Clinical Research Assistant at Yuva Intern by Henry Harvin, shared on LinkedIn: ''Hematopoietic…
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Apr 2, 2026, 13:51 | Drugs
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Clare Woodford, Head of Policy and Influencing at The Stroke Association, shared on LinkedIn: ''NICE's…
All: 94 Posts: 1 - 10
NewsFeed